|Bid||13.18 x 1000|
|Ask||16.39 x 400|
|Day's range||14.15 - 14.36|
|52-week range||11.30 - 15.50|
|PE ratio (TTM)||159.33|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NEW YORK, Dec. 28, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Genomic Health, Inc. (NASDAQ:GHDX), Worthington Industries, Inc. (NYSE:WOR), Rambus, Inc. (NASDAQ:RMBS), OMNOVA Solutions Inc. (NYSE:OMN), CAI International, Inc. (NYSE:CAI), and Rudolph Technologies, Inc. (NYSE:RTEC), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
The senior notes offering will lower Rambus' (RMBS) cost of capital, thus strengthening its balance sheet and supporting growth.
On a per-share basis, the Sunnyvale, California-based company said it had net income of 7 cents. Earnings, adjusted for one-time gains and costs, were 19 cents per share. The results surpassed Wall Street ...
Rambus Inc.'s (RMBS) licensing agreements, acquisition synergies, strategic deals and restructuring initiatives are likely to drive the company's overall Q3 results.